Expert Diagnosis is Key!
Comprehensive evaluation with accurate diagnosis is the foundation for
achieving successful outcomes. That’s why it’s important to
seek care from a center that provides academic level care from a multidisciplinary,
specialized team of hepatobiliary and pancreatic experts experienced in
the accurate diagnosis of pancreatic cancer, as well as other complex
Beginning with a thorough evaluation that includes a comprehensive physical
exam, personal medical history review and state-of-the-art diagnostic
workup, Hoag’s multidisciplinary team of board-certified, fellowship
trained hepatobiliary and pancreatic experts carefully evaluate and pinpoint
the nature of the cancer, so the most appropriate personalized treatment
options can be employed.
Hoag’s state-of-the-art diagnostic technologies provide our team
with the latest modalities in the accurate diagnosis of pancreatic cancer
and other disorders. Some of the progressive imaging studies that may
be utilized include:
Volume Rendering Computed Tomography (CT) is the most recent advance in CT technology. Only a few centers in Southern
California have this technology, which creates highly accurate 3-D scans
of the pancreas. This enables physicians to properly stage the cancer
and determine whether the tumor is resectable.
Endoscopic Ultrasound (EUS) uses an ultrasound device to make images of your pancreas from inside your
abdomen. The physician may also collect a sample of cells (biopsy) during EUS.
Endoscopic Retrograde Cholangiopancreatography (ERCP) uses a dye to highlight the bile ducts in the pancreas, so that an accurate
image of the bile duct and pancreatic duct may be obtained. This study
is performed to rule out certain diseases of the pancreas and the bile
duct. The physician may also insert small tubes (called stents) into the
bile duct or the pancreatic duct, if they are obstructed, to relieve the
obstruction. Additionally, a tissue sample (biopsy) may be collected during ERCP.
MRCP is a modified MRI that utilizes specialized software to obtain a composite
image of the pancreatic duct and the bile duct from the digital MRI images.
This study provides similar information to an ERCP. However, as a diagnostic
study, MRCP study is preferred to ERCP since this procedure is not invasive.
Tumor Markers are used to determine whether certain substances are being released into
the blood. Tumor markers are often obtained to assess the probability
of a cancer in a patient who has a lesion. While high tumor markers may
indicate cancer, they are not definitive since non-cancerous conditions
of the pancreas and liver can falsely elevate these tumor markers.
Diagnostic Laparoscopy is a minimally invasive surgical procedure used to examine internal organs
by direct visualization. Small incisions are made in the abdominal wall,
and a thin, lighted tube called a laparoscope is inserted. This procedure
allows the surgeon to evaluate whether the cancer has spread outside of
the pancreas prior to performing surgery. This is an important part of
planning for surgery.
Biopsy is the removal of a sample of tissue for testing. This procedure is performed
to definitively diagnose pancreatic cancer, and may involve other methods
outside of laparoscopic biopsy, such as endoscopic ultrasound or fine-needle
It’s important to note that proper diagnosis and staging of pancreatic
cancer is critical to developing a successful treatment plan. That’s
why it’s so important to seek proper evaluation and treatment from
a healthcare expert experienced in the most advanced hepatobiliary and
pancreatic cancer care.
Innovative Treatment for Pancreatic Cancer
When it comes to pancreatic cancer and other gastrointestinal diseases,
Hoag Family Cancer Institute, in collaboration with pancreatic cancer
specialists and USC Norris Comprehensive Cancer Center, provides a full
array of progressive treatment options. As a recognized leader and high-volume
provider of innovative gastrointestinal care, Hoag’s multidisciplinary
team of digestive disease experts performs some of the most advanced gastrointestinal
procedures available in the nation with clinical outcomes that rival national figures.
Expert Care You Can Trust!
Hoag Family Cancer Institute, in collaboration with digestive disorder
physician specialists, USC Care Medical Group and USC Norris Comprehensive
Cancer Center, provide state-of-the-art complex hepatobiliary and pancreatic
cancer care. Hoag’s committed to accurate diagnosis, combined with
progressive therapeutic options enables Hoag patients to achieve some
of the highest clinical outcomes in the nation.
To schedule a comprehensive diagnostic evaluation, or a second-opinion
consultation with a Hoag pancreatic cancer expert, call us at 949-764-5350.